Casdin Capital as of March 31, 2021
Portfolio Holdings for Casdin Capital
Casdin Capital holds 48 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invitae (NVTAQ) | 13.9 | $466M | 12M | 38.21 | |
| EXACT Sciences Corporation (EXAS) | 9.3 | $311M | 2.4M | 131.78 | |
| Fate Therapeutics (FATE) | 8.3 | $280M | 3.4M | 82.45 | |
| Biolife Solutions Com New (BLFS) | 8.0 | $268M | 7.4M | 36.00 | |
| Pacific Biosciences of California (PACB) | 5.0 | $167M | 5.0M | 33.31 | |
| Blueprint Medicines (BPMC) | 4.5 | $151M | 1.6M | 97.23 | |
| Alnylam Pharmaceuticals (ALNY) | 3.7 | $124M | 880k | 141.19 | |
| Twist Bioscience Corp (TWST) | 3.7 | $124M | 1.0M | 123.86 | |
| Relay Therapeutics (RLAY) | 3.5 | $117M | 3.4M | 34.57 | |
| Agios Pharmaceuticals (AGIO) | 3.3 | $112M | 2.2M | 51.64 | |
| Codexis (CDXS) | 3.0 | $99M | 4.3M | 22.89 | |
| Denali Therapeutics (DNLI) | 2.7 | $92M | 1.6M | 57.10 | |
| Dermtech Ord ord (DMTKQ) | 2.6 | $89M | 1.7M | 50.79 | |
| Revolution Medicines (RVMD) | 2.5 | $85M | 1.8M | 45.88 | |
| Caredx (CDNA) | 2.4 | $81M | 1.2M | 68.09 | |
| Beam Therapeutics (BEAM) | 2.0 | $66M | 819k | 80.04 | |
| Beigene Sponsored Adr (BGNE) | 1.6 | $52M | 150k | 348.08 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.4 | $46M | 1.2M | 40.26 | |
| Allogene Therapeutics (ALLO) | 1.4 | $46M | 1.3M | 35.30 | |
| Generation Bio (GBIO) | 1.4 | $46M | 1.6M | 28.46 | |
| 4d Molecular Therapeutics In (FDMT) | 1.3 | $43M | 995k | 43.38 | |
| Constellation Pharmceticls I | 1.3 | $42M | 1.8M | 23.39 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $41M | 550k | 74.53 | |
| Magenta Therapeutics | 1.2 | $40M | 3.3M | 11.84 | |
| Global Blood Therapeutics In | 1.1 | $37M | 900k | 40.75 | |
| Alector (ALEC) | 1.0 | $33M | 1.7M | 20.14 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $33M | 266k | 121.85 | |
| Zai Lab Adr (ZLAB) | 0.8 | $25M | 190k | 133.43 | |
| Orchard Therapeutics Ads | 0.7 | $23M | 3.2M | 7.26 | |
| Burning Rock Biotech Sponsored Adr | 0.7 | $23M | 847k | 26.92 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $22M | 1.0M | 22.36 | |
| Adverum Biotechnologies | 0.6 | $22M | 2.2M | 9.86 | |
| 908 Devices (MASS) | 0.6 | $20M | 407k | 48.50 | |
| Kronos Bio (KRON) | 0.5 | $17M | 583k | 29.27 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $17M | 820k | 20.30 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $15M | 602k | 24.50 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $15M | 1.2M | 11.78 | |
| Decibel Therapeutics | 0.4 | $13M | 1.1M | 11.36 | |
| Berkeley Lts | 0.3 | $10M | 200k | 50.23 | |
| Dyne Therapeutics (DYN) | 0.3 | $9.5M | 610k | 15.53 | |
| Seer Com Cl A (SEER) | 0.2 | $7.5M | 150k | 50.02 | |
| Turning Point Therapeutics I | 0.2 | $7.1M | 75k | 94.59 | |
| Sangamo Biosciences (SGMO) | 0.2 | $6.9M | 550k | 12.53 | |
| Clover Health Investments Com Cl A (CLOV) | 0.2 | $5.5M | 727k | 7.56 | |
| Stoke Therapeutics (STOK) | 0.1 | $4.7M | 120k | 38.84 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $2.9M | 216k | 13.18 | |
| Sana Biotechnology (SANA) | 0.1 | $2.0M | 60k | 33.47 | |
| Codiak Biosciences | 0.0 | $1.2M | 77k | 15.07 |
